March 27, 2019

Reclassification of Early Stage Breast Cancer Into Treatment Groups by Combining the Use of Immunohistochemistry and Microarray Analysis

Vol 115 No 3/4 (2019): South African Journal of Science.

Kathleen A. Grant; Ettienne J. Myburgh; Elizabeth Murray; Fredrieka M. Pienaar; Martin Kidd; Colleen A. Wright; Maritha J. Kotze

Neither single-gene genomic mRNA nor IHC reporting of ER and PR status can replace the combined use of MammaPrint/BluePrint genomic molecular subtyping. -128 patients.

Read more: Grant et al_2019_South African Journal of Science_Use of MammaPrint/BluePrint genomic molecular subtyping